blood loss Clinical Trials

1 recruiting

blood loss Trials at a Glance

23 actively recruiting trials for blood loss are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Alexandria, Alexandria, and Ann Arbor. Lead sponsors running blood loss studies include Alexandria University, Assiut University, and Ascension Health.

Browse blood loss trials by phase

Treatments under study

About blood loss Clinical Trials

Looking for clinical trials for blood loss? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new blood loss trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about blood loss clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Phase 3

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Surgical Blood LossTransfusion-dependent AnemiaAbdomen Disease
Ulrich Ronellenfitsch, MD850 enrolled2 locationsNCT06414031
Recruiting
Phase 3

Tranexamic Acid in Adult Spinal Deformity Surgery

Blood Loss, SurgicalSpinal DeformityDegenerative Lumbar Spinal Stenosis
Hospital for Special Surgery, New York100 enrolled1 locationNCT03553186
Recruiting
Not Applicable

PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery.

Postoperative PainSurgical Blood LossLumbar Spinal Fusion Surgery
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau62 enrolled2 locationsNCT07550114
Recruiting

Hemophilia A Research Program

PregnancyHemophilia APregnancy Complications+10 more
University of Washington500 enrolled1 locationNCT07414511
Recruiting

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

MicrobiomeCritical IllnessTrauma+3 more
University of Florida275 enrolled3 locationsNCT06606119
Recruiting
Not Applicable

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Uterine Fibroids (Leiomyoma)MyomectomyMyomectomy; Surgical Blood Loss
Alexandria University60 enrolled2 locationsNCT07352761
Recruiting
Phase 2

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Blood Loss, SurgicalBlood Loss, Postoperative
University of Michigan140 enrolled1 locationNCT07217899
Recruiting
Not Applicable

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

Myomectomy; Surgical Blood LossMyoma;Uterus
University Hospital, Clermont-Ferrand80 enrolled1 locationNCT06882824
Recruiting
Not Applicable

Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery

Adverse Drug EventFibrinolysis; HemorrhageBlood Coagulation Disorder+2 more
University of Ioannina150 enrolled1 locationNCT07164300
Recruiting

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

Pain, PostoperativeCystectomyAnaemia+3 more
Goethe University60 enrolled1 locationNCT07008261
Recruiting
Phase 4

Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

FractureAcute Blood Loss Anemia
Oregon Health and Science University150 enrolled1 locationNCT05292001
Recruiting

Safe and Timely Antithrombotic Removal (STAR) Registry

Blood Loss, SurgicalBlood Loss, PostoperativeHemorrhage, Surgical+1 more
CytoSorbents, Inc1,000 enrolled30 locationsNCT05077124
Recruiting
Not Applicable

Red Blood Cell Transfusion in ECMO - A Feasibility Trial

Disability PhysicalCognitive Ability, GeneralExtracorporeal Membrane Oxygenation Complication+2 more
Australian and New Zealand Intensive Care Research Centre120 enrolled2 locationsNCT05814094
Recruiting
Not Applicable

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Tumor of PancreasSurgical Blood Loss
Zhejiang University30 enrolled1 locationNCT06164769
Recruiting
Phase 1

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

SurgeryPostoperative Blood Loss
Vanderbilt University Medical Center60 enrolled1 locationNCT05774717
Recruiting
Not Applicable

EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER

Prostate Cancer (Adenocarcinoma)Blood Loss, PostoperativeErectile Function
St. Antonius Hospital Gronau362 enrolled3 locationsNCT06822036
Recruiting
Early Phase 1

Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score

Blood Loss, Surgical
Assiut University90 enrolled1 locationNCT06725732
Recruiting
Phase 1

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Blood Loss, Surgical
University of Manitoba24 enrolled1 locationNCT01731444
Recruiting
Not Applicable

Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil

Blood Loss, SurgicalCardiovascular Surgery
Instituto Materno Infantil Prof. Fernando Figueira60 enrolled1 locationNCT06601582
Recruiting
Not Applicable

Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial

Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy
Zagazig University60 enrolled1 locationNCT06566352